Trial Profile
Efficacy and Safety of Melatonin and Rivotril Treatment for Idiopathic Rapid Eye Movement Sleep Disorder: Prospective Randomized Study
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Melatonin (Primary) ; Clonazepam
- Indications REM-sleep-behavior-disorder
- Focus Therapeutic Use
- 18 Feb 2021 Status changed from recruiting to completed.
- 25 Feb 2019 Planned End Date changed from 1 Sep 2018 to 30 Dec 2019.
- 25 Feb 2019 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2019.